NCT06022380View on ClinicalTrials.gov

Core Outcome Set for Head, Neck and Respiratory Disease in Mucopolysaccharidosis II

CompletedOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

September 28, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Mucopolysaccharidosis Type II
Trial Locations (1)

M13 9WL

Manchester University NHS Foundation Trust, Manchester

All Listed Sponsors
lead

Manchester University NHS Foundation Trust

OTHER_GOV

NCT06022380 - Core Outcome Set for Head, Neck and Respiratory Disease in Mucopolysaccharidosis II | Biotech Hunter | Biotech Hunter